ARCADIA GROUP, LLC – Trademark Portfolio

Entity Type: 16

ARCADIA GROUP, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PHAZIX. The owner is based in ATLANTA, GA.

3235 ROSWELL ROAD #606

ATLANTA, GA 30305

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PHAZIX
PHAZIX
Registered 2019
CHOICE
CHOICE
Cancelled 2018

Trademark Classifications

ARCADIA GROUP, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does ARCADIA GROUP, LLC have?

ARCADIA GROUP, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.

What trademark classes does ARCADIA GROUP, LLC file in?

ARCADIA GROUP, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ARCADIA GROUP, LLC's most well-known trademarks?

ARCADIA GROUP, LLC's registered trademark portfolio includes well-known marks such as PHAZIX. These are among 1 currently registered trademark in the portfolio.

What is ARCADIA GROUP, LLC's trademark registration success rate?

ARCADIA GROUP, LLC has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.